The leading microbiome company in oncology

We are a clinical-stage microbiome therapeutics company
aiming to improve survival in cancer.

Our strengths

A full ecosystem approach

Oncology focused

AI-Powered Drug Development

cGMP Versatile Manufacturing Capacities

Latest News

November 7, 2024

November 7, 2024: MaaT Pharma to Present Updates from Early Access Program at the 2024 ASH Annual Meeting Demonstrating Prolonged Long-Term Survival in Patients Receiving MaaT013 in aGvHD

November 5, 2024

November 5, 2024: MaaT Pharma Provides Third Quarter 2024 Business and Financial Results and Announces Management Changes

October 29, 2024

October 25, 2024: Le Journal des biotechs : Hervé Affagard, MaaT Pharma (French only)

Like what you see? See more posts

Our upcoming events

Event
November 20, 2024

SFGM-TC Annual Congress

• November 20-22, 2024 – SFGM-TC Annual Congress
MaaT Pharma
Event
November 20, 2024

Deutsches Eigenkapitalforum

• November 25-27, 2024 – Deutsches Eigenkapitalforum
MaaT Pharma
Event
November 20, 2024

Investir Day Event

• November 26, 2024 – Investir Day Event
MaaT Pharma

Join the MaaT Pharma adventure!

Bring your talents, your passion and join an inclusive, creative, and multidisciplinary team. We aim to leverage the potential of microbiome to improve the treatment of patients with cancer.

Learn more about our values, our environment and see what we have to offer to you!

Careers